{
  "meta": {
    "timestamp": "2025-01-06T13:36:09.128872",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "AKOYA BIOSCIENCES INC COM",
      "symbol": "AKYA",
      "analysis": {
        "historical": {
          "risk_score": 60,
          "key_risks": [
            "Supply chain vulnerabilities impacting production and delivery timelines",
            "Intense competition in the spatial biology market",
            "Regulatory challenges for clinical applications",
            "Pricing pressure from budget constraints in academic and research institutions",
            "Increased short interest indicating investor skepticism"
          ],
          "controversies": [],
          "environmental_issues": [],
          "social_issues": [],
          "governance_issues": [],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. - AnnualReports.com",
              "snippet": "As The Spatial Biology Company\u00ae, Akoya Biosciences' mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The Company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM supply chain disruptions lawsuits",
              "retrieved_at": "2025-01-06T20:35:43.316359+00:00",
              "published_date": null,
              "source_hash": "037e529ebdfcfe3450ac3908fdc942ab"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. (AKYA) - Yahoo Finance",
              "snippet": "Find the latest Akoya Biosciences, Inc. (AKYA) stock quote, history, news and other vital information to help you with your stock trading and investing.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283277+00:00",
              "published_date": null,
              "source_hash": "7e0c870fbe3ee7379e8be15d744801a3"
            },
            {
              "url": "",
              "title": "Investor Relations | Akoya Biosciences, Inc.",
              "snippet": "As The Spatial Biology Company\u00ae, Akoya Biosciences' mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283192+00:00",
              "published_date": null,
              "source_hash": "542c3c82ff708f0899b6f8ff02480dd4"
            },
            {
              "url": "",
              "title": "Corporate Profile - Akoya Biosciences, Inc.",
              "snippet": "As The Spatial Biology Company\u00ae, Akoya Biosciences' mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283252+00:00",
              "published_date": null,
              "source_hash": "e3befe6c026727a18359ea8b4d6b3a39"
            },
            {
              "url": "",
              "title": "Akoya Biosciences - Overview, News & Similar companies - ZoomInfo",
              "snippet": "Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences MARLBOROUGH, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (\"Akoya\"), The Spatial Biology Company\u00ae, today announced that it will release financial results for the second quarter of 2024 after the market closes on Monday ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283304+00:00",
              "published_date": null,
              "source_hash": "a7aac6e94474b5986ad91178afe95cf8"
            },
            {
              "url": "",
              "title": "The Spatial Biology Company | Akoya Biosciences",
              "snippet": "Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies... Akoya Biosciences' Technology Enables Queensland Spatial Biology Centre to Revolutionize... Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283267+00:00",
              "published_date": null,
              "source_hash": "c8d89afab42565ab520877b2584a02c9"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. Company Overview, Contact Details & Competitors ...",
              "snippet": "Expansion Opportunities Akoya Biosciences has recently opened a new Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts, indicating potential growth and expansion opportunities. This development could pave the way for increased business partnerships and collaborations in the region. Unique Product Offering With the launch of innovative solutions like the PhenoCode ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283315+00:00",
              "published_date": null,
              "source_hash": "15d7970c09f728f7471e43d16c162427"
            },
            {
              "url": "",
              "title": "News Releases - Akoya Biosciences, Inc.",
              "snippet": "MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (\"Akoya\"), The Spatial Biology Company \u00ae , today announced its financial results for the first quarter ending March 31, 2024. Business Highlights Revenue was $18.4 million in the first quarter of 2024,... Continue Reading.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:49.288154+00:00",
              "published_date": null,
              "source_hash": "242d2a0e5aef993ab7068b125fdedafa"
            },
            {
              "url": "",
              "title": "AKOYA BIOSCIENCES, INC. Company Profile - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for AKOYA BIOSCIENCES, INC. of Menlo Park, CA. Get the latest business insights from Dun & Bradstreet.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM supply chain disruptions lawsuits",
              "retrieved_at": "2025-01-06T20:35:43.316485+00:00",
              "published_date": null,
              "source_hash": "1db9d6f6d287244392d69272f2398bb5"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. (AKYA) Company Profile & Overview - Stock Analysis",
              "snippet": "Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:49.288199+00:00",
              "published_date": null,
              "source_hash": "ccd0521b64cc5c5f435634120b5323d2"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. (AKYA)",
              "snippet": "Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare's Immunoprint test for prognostication of disease recurrence in early-stage melanoma ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:55.778815+00:00",
              "published_date": "2024-12-27T00:00:00+00:00",
              "source_hash": "f6d112e92e43cdffcee91fe4fb109fad"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 20.7% in December",
              "snippet": "Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 1,",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:55.778844+00:00",
              "published_date": "2024-12-31T06:29:00+00:00",
              "source_hash": "68b79f477bd6aa315bf9b200735609a2"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives $5.43 Average Target Price from Analysts",
              "snippet": "Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) has earned an average recommendation of \"Hold\" from the seven analysts that are currently covering the company, MarketBeat reports.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:55.778868+00:00",
              "published_date": "2025-01-02T00:00:00+00:00",
              "source_hash": "1bedc77fc0f31df26bc52f9530fe9705"
            },
            {
              "url": "",
              "title": "Akoya Biosciences Reports Third Quarter 2024 Financial Results",
              "snippet": "MARLBOROUGH, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (\"Akoya\"), The Spatial Biology Company\u00ae, today announced its ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:51.761371+00:00",
              "published_date": "2024-09-30T00:00:00+00:00",
              "source_hash": "f7e6ddfc682cdd693d05cd8ca859c0c1"
            },
            {
              "url": "",
              "title": "Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the ...",
              "snippet": "MARLBOROUGH, Mass. and FRANKFURT, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company, and NeraCare, a ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM supply chain disruptions lawsuits",
              "retrieved_at": "2025-01-06T20:35:45.804757+00:00",
              "published_date": "2024-12-10T00:00:00+00:00",
              "source_hash": "c814f294e7f4ee3f6502e2e43260b48d"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. Company Overview, Contact Details & Competitors ...",
              "snippet": "Find more Akoya Biosciences, Inc. email formats with LeadIQ. How much funding has Akoya Biosciences, Inc. raised to date? As of November 2024, Akoya Biosciences, Inc. has raised $44M in funding. The last funding round occurred on Jun 07, 2023 for $44M. When was Akoya Biosciences, Inc. founded? Akoya Biosciences, Inc. was founded in 2015.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:49.288121+00:00",
              "published_date": null,
              "source_hash": "e1ca0b1b8319fbf045d476c210852efb"
            },
            {
              "url": "",
              "title": "Akoya Biosciences Reports First Quarter 2024 Financial Results",
              "snippet": "MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (\"Akoya\"), The Spatial Biology Company \u00ae , today announced its financial results for the first quarter ending March 31, 2024. Business Highlights Revenue was $18.4 million in the first quarter of 2024,",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:49.288164+00:00",
              "published_date": null,
              "source_hash": "002c41ced7b4003bcb603eec32aec692"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, Inc. Company Profile - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for Akoya Biosciences, Inc. of Marlborough, MA. Get the latest business insights from Dun & Bradstreet. Akoya Biosciences, Inc.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283333+00:00",
              "published_date": null,
              "source_hash": "f9a3cda59d87bc743357bea0e28814a1"
            },
            {
              "url": "",
              "title": "Company Akoya Biosciences, Inc. - MarketScreener.com",
              "snippet": "Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:49.288182+00:00",
              "published_date": null,
              "source_hash": "be2b75896605ebe8d77bda95d742b459"
            },
            {
              "url": "",
              "title": "Akoya Biosciences Inc - Company Profile and News",
              "snippet": "Akoya Biosciences, Inc. provides spatial biology solutions. The Company offers end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:49.288190+00:00",
              "published_date": null,
              "source_hash": "20a5ab3bde42d35f6be20a11ecda3f9e"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma",
              "snippet": "Akoya Biosciences, Inc., the spatial biology company, and NeraCare, a leading developer of laboratory tests for the prognosis of melanoma, announced an exclusive global license agreement to develop and commercialize NeraCare's Immunoprint test on Akoya's ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "retrieved_at": "2025-01-06T20:35:51.761380+00:00",
              "published_date": "2024-12-12T17:00:00+00:00",
              "source_hash": "0747c6d9c9d948e942bd0fab5ee2ac6c"
            },
            {
              "url": "",
              "title": "News Releases - Akoya Biosciences, Inc.",
              "snippet": "MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (\"Akoya\"), The Spatial Biology Company \u00ae , today announced its financial results for the first quarter ending March 31, 2024. Business Highlights Revenue was $18.4 million in the first quarter of 2024,...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283286+00:00",
              "published_date": null,
              "source_hash": "2b283ecdaacfb9fcf2052d0374801924"
            },
            {
              "url": "",
              "title": "Akoya Biosciences Inc: Business Model, SWOT Analysis, and Competitors ...",
              "snippet": "Regulatory Challenges: Navigating the complex regulatory landscape can pose challenges for product development and approval. Economic Downturns: Economic instability can lead to reduced funding for research, ... Akoya Biosciences Inc. is known for its innovative technologies in spatial biology, specifically its imaging systems that allow ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283295+00:00",
              "published_date": null,
              "source_hash": "1c9bf3fe3e43a05bb893fcfd1f460edb"
            },
            {
              "url": "",
              "title": "Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript ...",
              "snippet": "Despite efforts to streamline operations, Akoya Biosciences Inc (NASDAQ:AKYA) faced challenges with inventory management, leading to a $2 million inventory write-off from discontinued legacy ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:53.283324+00:00",
              "published_date": null,
              "source_hash": "5f08586a8f3625a69c7130704dd0aab6"
            },
            {
              "url": "",
              "title": "Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma",
              "snippet": "Akoya Biosciences, Inc., the spatial biology company ... diagnostic development or, following regulatory approval, patient clinical testing as both a laboratory test or a distributable diagnostic on Akoya's PhenoImager HT platform. Melanoma, the leading ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:55.778858+00:00",
              "published_date": "2024-12-12T17:00:00+00:00",
              "source_hash": "a6c93171215d33ceb66c41c478415c0e"
            },
            {
              "url": "",
              "title": "Akoya Biosciences Reports Third Quarter 2024 Financial Results",
              "snippet": "Nov. 14, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA ... but we recognize the current environment will pose temporary challenges. We proactively anticipated this with ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "AKOYA BIOSCIENCES INC COM AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "retrieved_at": "2025-01-06T20:35:55.778878+00:00",
              "published_date": "2024-11-14T16:00:00+00:00",
              "source_hash": "ce267633792be55abea39524f836c3e5"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "AKOYA BIOSCIENCES INC COM supply chain disruptions lawsuits",
              "rationale": "Investigate legal risks related to supply chain vulnerabilities and potential lawsuits",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "AKOYA BIOSCIENCES INC COM pricing pressure controversies",
              "rationale": "Explore ethical concerns or backlash related to pricing strategies and affordability for academic institutions",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "AKOYA BIOSCIENCES INC COM regulatory challenges FDA",
              "rationale": "Assess risks tied to regulatory hurdles, particularly FDA approvals for clinical applications",
              "priority": 1
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T13:36:09.128881",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}